Literature DB >> 22732586

B7-CD28 costimulatory signals control the survival and proliferation of murine and human γδ T cells via IL-2 production.

Julie C Ribot1, Ana Debarros, Liliana Mancio-Silva, Ana Pamplona, Bruno Silva-Santos.   

Abstract

γδ T cells play key nonredundant roles in immunity to infections and tumors. Thus, it is critical to understand the molecular mechanisms responsible for γδ T cell activation and expansion in vivo. In striking contrast to their αβ counterparts, the costimulation requirements of γδ T cells remain poorly understood. Having previously described a role for the TNFR superfamily member CD27, we since screened for other nonredundant costimulatory receptors in γδ T cell activation. We report in this article that the Ig superfamily receptor CD28 (but not its related protein ICOS) is expressed on freshly isolated lymphoid γδ T cells and synergizes with the TCR to induce autocrine IL-2 production that promotes γδ cell survival and proliferation in both mice and humans. Specific gain-of-function and loss-of-function experiments demonstrated a nonredundant function for CD28 interactions with its B7 ligands, B7.1 (CD80) and B7.2 (CD86), both in vitro and in vivo. Thus, γδ cell proliferation was significantly enhanced by CD28 receptor agonists but abrogated by B7 Ab-mediated blockade. Furthermore, γδ cell expansion following Plasmodium infection was severely impaired in mice genetically deficient for CD28. This resulted in the failure to mount both IFN-γ-mediated and IL-17-mediated γδ cell responses, which contrasted with the selective effect of CD27 on IFN-γ-producing γδ cells. Our data collectively show that CD28 signals are required for IL-2-mediated survival and proliferation of both CD27(+) and CD27(-) γδ T cell subsets, thus providing new mechanistic insight for their modulation in disease models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732586     DOI: 10.4049/jimmunol.1200268

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Authors:  Hamid Reza Mirzaei; Hamed Mirzaei; Sang Yun Lee; Jamshid Hadjati; Brian G Till
Journal:  Cancer Lett       Date:  2016-07-05       Impact factor: 8.679

2.  EPCR: a stress trigger for γδ T cells.

Authors:  Deborah A Witherden; Wendy L Havran
Journal:  Nat Immunol       Date:  2012-09       Impact factor: 25.606

3.  Characterization of γδ T cells in patients with non-small cell lung cancer.

Authors:  Yi Bao; Li Guo; Juanfen Mo
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

4.  Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D.

Authors:  Anne Y Lai; Arpita Patel; Faraha Brewer; Kinsley Evans; Kellsey Johannes; Louis E González; Kyung Jin Yoo; George Fromm; Keith Wilson; Taylor H Schreiber; Suresh de Silva
Journal:  J Immunol       Date:  2022-09-12       Impact factor: 5.426

Review 5.  IL-17+ γδ T cells as kick-starters of inflammation.

Authors:  Pedro H Papotto; Julie C Ribot; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

6.  Loss and dysfunction of Vδ2⁺ γδ T cells are associated with clinical tolerance to malaria.

Authors:  Prasanna Jagannathan; Charlie C Kim; Bryan Greenhouse; Felistas Nankya; Katherine Bowen; Ijeoma Eccles-James; Mary K Muhindo; Emmanuel Arinaitwe; Jordan W Tappero; Moses R Kamya; Grant Dorsey; Margaret E Feeney
Journal:  Sci Transl Med       Date:  2014-08-27       Impact factor: 17.956

7.  Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patients.

Authors:  Zhiming Lin; Qu Lin; Zetao Liao; Qiuxia Li; Fucheng Zhang; Qiujing Wei; Shuangyan Cao; Jieruo Gu
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

8.  SerpinB1 regulates homeostatic expansion of IL-17+ γδ and CD4+ Th17 cells.

Authors:  Picheng Zhao; Lifei Hou; Kalamo Farley; Mark S Sundrud; Eileen Remold-O'Donnell
Journal:  J Leukoc Biol       Date:  2013-11-18       Impact factor: 4.962

Review 9.  Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation.

Authors:  Sérgio T Ribeiro; Julie C Ribot; Bruno Silva-Santos
Journal:  Front Immunol       Date:  2015-01-26       Impact factor: 7.561

10.  γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulation.

Authors:  Renee M Laird; Benjamin J Wolf; Michael F Princiotta; Sandra M Hayes
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.